Literature DB >> 8919263

A lymphatic function of Daflon 500 mg.

C Labrid1.   

Abstract

UNLABELLED: The lymphagogue activity of a micronized, purified flavonoidic fraction, Daflon 500 mg (D) (diosmin 90%+ hesperidin 10%) was tested in dogs and rats.
METHODS: In the anaesthetized mongrel dog measurement of lymphatic flow was carried out in a thoracic duct fistula inserted 30 min prior to I.V. injection of D (3.125; 6.250 and 12.500 mg/kg-1). Lymph was collected every 10 min for 200 min. Using the same experimental model 14C-diosmin transfer from blood to lymph was studied after I.V. infusion (5 min) of 14C-diosmin (50 muCi)+D(12.5 mg/kg-1) in the saphenous vein. Similar experiments were performed in the rat after oral treatment.
RESULTS: D induced an important lymphatic flow increase which was correlated with the administered doses. The maximal 10 min period flow after I.V. injection of D (12.500 mg/kg-1) was 191% higher than the corresponding one in the control group. A correlation between lymphatic flow increase and pulsatility was demonstrated. Infusion of 14C-labelled-D evidenced a clear blood-lymph transfer of the drug: an active transport into the lymph was suggested during a 15 min-100 min period from the concentration curves.
CONCLUSIONS: The improvement of lymphatic drainage displayed by D seems to be an important component of its beneficial effect on perivascular edema.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8919263

Source DB:  PubMed          Journal:  Int Angiol        ISSN: 0392-9590            Impact factor:   2.789


  3 in total

1.  Flavonoids mixture (diosmin, troxerutin, hesperidin) in the treatment of acute hemorrhoidal disease: a prospective, randomized, triple-blind, controlled trial.

Authors:  I Giannini; A Amato; L Basso; N Tricomi; M Marranci; G Pecorella; S Tafuri; D Pennisi; D F Altomare
Journal:  Tech Coloproctol       Date:  2015-04-19       Impact factor: 3.781

Review 2.  Hemorrhoids: from basic pathophysiology to clinical management.

Authors:  Varut Lohsiriwat
Journal:  World J Gastroenterol       Date:  2012-05-07       Impact factor: 5.742

3.  Uncommon serum creatine phosphokinase and lactic dehydrogenase increase during diosmin therapy: two case reports.

Authors:  Giulia Milano; Silvia Leone; Carmen Fucile; Maria Laura Zuccoli; Andrea Stimamiglio; Antonietta Martelli; Francesca Mattioli
Journal:  J Med Case Rep       Date:  2014-06-16
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.